A dosimetric comparison of non-coplanar volumetric modulated arc therapy and non-coplanar fixed field intensity modulated radiation therapy in hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for brain metastases

ObjectiveThe aim of this study was to investigate the dosimetric differences between non-coplanar volumetric modulated arc therapy (VMAT) and non-coplanar fixed-field intensity-modulated radiotherapy (IMRT) in hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost (...

Full description

Saved in:
Bibliographic Details
Main Authors: Huaqu Zeng, MinZhi Zhong, Zongyou Chen, Shukui Tang, Zunbei Wen
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1428329/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832590855236485120
author Huaqu Zeng
MinZhi Zhong
Zongyou Chen
Shukui Tang
Zunbei Wen
author_facet Huaqu Zeng
MinZhi Zhong
Zongyou Chen
Shukui Tang
Zunbei Wen
author_sort Huaqu Zeng
collection DOAJ
description ObjectiveThe aim of this study was to investigate the dosimetric differences between non-coplanar volumetric modulated arc therapy (VMAT) and non-coplanar fixed-field intensity-modulated radiotherapy (IMRT) in hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost (HA-WBRT+SIB) for brain metastases using the Monaco treatment planning system (TPS).MethodA total of 22 patients with brain metastases were retrospectively enrolled. Two radiotherapy treatment plans were designed for each patient: non-coplanar VMAT and non-coplanar fixed field IMRT. The dose distribution of targets and organs at risk (OAR), the number of monitor units (MUs), and pre-treatment plan verification were compared between the two plans while meeting the prescribed dose requirements of the target volume.ResultsThere were no significant differences in V50, V55, Dmax, heterogeneity index (HI) and conformity index (CI) of target PGTV between the two plans (p>0.05). For PTV-brain-SIB, there was no significant difference in D98% between IMRT and VMAT (p=0.103). VMAT significantly improved the V30 of PTV-brain-SIB (p<0.001), decreased HI (p=0.003), and increased CI (p<0.001). There were no significant differences in the Dmax to the brain stem, left and right lens, optic chiasm, pituitary gland, and left and right hippocampus between the two plans (p>0.05). Compared with IMRT, VMAT significantly reduced the Dmax to the left and right eyes (p<0.001) and significantly increased the Dmax to the right inner ear (p=0.010). There was no significant difference in the Dmax to the left inner ear between VMAT and IMRT (p=0.458). Compared with IMRT, VMAT significantly reduced the Dmax to the left optic nerve (p=0.006), but significantly increased the Dmax to the right optic nerve (p=0.001). There was no significant difference in the Dmax to the left and right hippocampus between VMAT and IMRT (p>0.05), but VMAT significantly increased the D100% (p<0.05) compared with IMRT. Compared with VMAT, IMRT significantly reduced the MU (p<0.001) but VMAT has a higher treatment efficiency than IMRT, with an average reduction of 41 seconds (294.1 ± 16.4 s for VMAT, 335.8 ± 34.9 s for IMRT, p<0.001). Under the conditions of 3%/2 mm, and 2%/2 mm, the gamma passing rate of the IMRT QA was improved compared to VMAT, with an average increase of 0.6%, p=0.013, and 1.7%, p<0.001, respectively.ConclusionBoth non-coplanar VMAT and non-coplanar fixed field IMRT based on the Monaco TPS produce clinically acceptable results for HA-WBRT+SIB in patients with brain metastases. Compared with IMRT, VMAT has better dose distribution in the target volume and treatment efficiency, but IMRT can better protect the hippocampus and reduce the number of MUs.
format Article
id doaj-art-f2c7e95690dc4fab815017ce0fb1bff8
institution Kabale University
issn 2234-943X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-f2c7e95690dc4fab815017ce0fb1bff82025-01-23T06:56:36ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-01-011410.3389/fonc.2024.14283291428329A dosimetric comparison of non-coplanar volumetric modulated arc therapy and non-coplanar fixed field intensity modulated radiation therapy in hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for brain metastasesHuaqu Zeng0MinZhi Zhong1Zongyou Chen2Shukui Tang3Zunbei Wen4Radiotherapy Center, Gaozhou People’s Hospital, Gaozhou, ChinaDepartment of Radiology, Guangzhou Red Cross Hospital, Guangzhou, ChinaRadiotherapy Center, Gaozhou People’s Hospital, Gaozhou, ChinaRadiotherapy Center, Gaozhou People’s Hospital, Gaozhou, ChinaRadiotherapy Center, Gaozhou People’s Hospital, Gaozhou, ChinaObjectiveThe aim of this study was to investigate the dosimetric differences between non-coplanar volumetric modulated arc therapy (VMAT) and non-coplanar fixed-field intensity-modulated radiotherapy (IMRT) in hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost (HA-WBRT+SIB) for brain metastases using the Monaco treatment planning system (TPS).MethodA total of 22 patients with brain metastases were retrospectively enrolled. Two radiotherapy treatment plans were designed for each patient: non-coplanar VMAT and non-coplanar fixed field IMRT. The dose distribution of targets and organs at risk (OAR), the number of monitor units (MUs), and pre-treatment plan verification were compared between the two plans while meeting the prescribed dose requirements of the target volume.ResultsThere were no significant differences in V50, V55, Dmax, heterogeneity index (HI) and conformity index (CI) of target PGTV between the two plans (p>0.05). For PTV-brain-SIB, there was no significant difference in D98% between IMRT and VMAT (p=0.103). VMAT significantly improved the V30 of PTV-brain-SIB (p<0.001), decreased HI (p=0.003), and increased CI (p<0.001). There were no significant differences in the Dmax to the brain stem, left and right lens, optic chiasm, pituitary gland, and left and right hippocampus between the two plans (p>0.05). Compared with IMRT, VMAT significantly reduced the Dmax to the left and right eyes (p<0.001) and significantly increased the Dmax to the right inner ear (p=0.010). There was no significant difference in the Dmax to the left inner ear between VMAT and IMRT (p=0.458). Compared with IMRT, VMAT significantly reduced the Dmax to the left optic nerve (p=0.006), but significantly increased the Dmax to the right optic nerve (p=0.001). There was no significant difference in the Dmax to the left and right hippocampus between VMAT and IMRT (p>0.05), but VMAT significantly increased the D100% (p<0.05) compared with IMRT. Compared with VMAT, IMRT significantly reduced the MU (p<0.001) but VMAT has a higher treatment efficiency than IMRT, with an average reduction of 41 seconds (294.1 ± 16.4 s for VMAT, 335.8 ± 34.9 s for IMRT, p<0.001). Under the conditions of 3%/2 mm, and 2%/2 mm, the gamma passing rate of the IMRT QA was improved compared to VMAT, with an average increase of 0.6%, p=0.013, and 1.7%, p<0.001, respectively.ConclusionBoth non-coplanar VMAT and non-coplanar fixed field IMRT based on the Monaco TPS produce clinically acceptable results for HA-WBRT+SIB in patients with brain metastases. Compared with IMRT, VMAT has better dose distribution in the target volume and treatment efficiency, but IMRT can better protect the hippocampus and reduce the number of MUs.https://www.frontiersin.org/articles/10.3389/fonc.2024.1428329/fullhippocampus sparingbrain metastasessimultaneous integrated boostwhole brain radiotherapyvolumetric modulated arc therapyintensity modulated radiotherapy
spellingShingle Huaqu Zeng
MinZhi Zhong
Zongyou Chen
Shukui Tang
Zunbei Wen
A dosimetric comparison of non-coplanar volumetric modulated arc therapy and non-coplanar fixed field intensity modulated radiation therapy in hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for brain metastases
Frontiers in Oncology
hippocampus sparing
brain metastases
simultaneous integrated boost
whole brain radiotherapy
volumetric modulated arc therapy
intensity modulated radiotherapy
title A dosimetric comparison of non-coplanar volumetric modulated arc therapy and non-coplanar fixed field intensity modulated radiation therapy in hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for brain metastases
title_full A dosimetric comparison of non-coplanar volumetric modulated arc therapy and non-coplanar fixed field intensity modulated radiation therapy in hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for brain metastases
title_fullStr A dosimetric comparison of non-coplanar volumetric modulated arc therapy and non-coplanar fixed field intensity modulated radiation therapy in hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for brain metastases
title_full_unstemmed A dosimetric comparison of non-coplanar volumetric modulated arc therapy and non-coplanar fixed field intensity modulated radiation therapy in hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for brain metastases
title_short A dosimetric comparison of non-coplanar volumetric modulated arc therapy and non-coplanar fixed field intensity modulated radiation therapy in hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for brain metastases
title_sort dosimetric comparison of non coplanar volumetric modulated arc therapy and non coplanar fixed field intensity modulated radiation therapy in hippocampus avoidance whole brain radiation therapy with a simultaneous integrated boost for brain metastases
topic hippocampus sparing
brain metastases
simultaneous integrated boost
whole brain radiotherapy
volumetric modulated arc therapy
intensity modulated radiotherapy
url https://www.frontiersin.org/articles/10.3389/fonc.2024.1428329/full
work_keys_str_mv AT huaquzeng adosimetriccomparisonofnoncoplanarvolumetricmodulatedarctherapyandnoncoplanarfixedfieldintensitymodulatedradiationtherapyinhippocampusavoidancewholebrainradiationtherapywithasimultaneousintegratedboostforbrainmetastases
AT minzhizhong adosimetriccomparisonofnoncoplanarvolumetricmodulatedarctherapyandnoncoplanarfixedfieldintensitymodulatedradiationtherapyinhippocampusavoidancewholebrainradiationtherapywithasimultaneousintegratedboostforbrainmetastases
AT zongyouchen adosimetriccomparisonofnoncoplanarvolumetricmodulatedarctherapyandnoncoplanarfixedfieldintensitymodulatedradiationtherapyinhippocampusavoidancewholebrainradiationtherapywithasimultaneousintegratedboostforbrainmetastases
AT shukuitang adosimetriccomparisonofnoncoplanarvolumetricmodulatedarctherapyandnoncoplanarfixedfieldintensitymodulatedradiationtherapyinhippocampusavoidancewholebrainradiationtherapywithasimultaneousintegratedboostforbrainmetastases
AT zunbeiwen adosimetriccomparisonofnoncoplanarvolumetricmodulatedarctherapyandnoncoplanarfixedfieldintensitymodulatedradiationtherapyinhippocampusavoidancewholebrainradiationtherapywithasimultaneousintegratedboostforbrainmetastases
AT huaquzeng dosimetriccomparisonofnoncoplanarvolumetricmodulatedarctherapyandnoncoplanarfixedfieldintensitymodulatedradiationtherapyinhippocampusavoidancewholebrainradiationtherapywithasimultaneousintegratedboostforbrainmetastases
AT minzhizhong dosimetriccomparisonofnoncoplanarvolumetricmodulatedarctherapyandnoncoplanarfixedfieldintensitymodulatedradiationtherapyinhippocampusavoidancewholebrainradiationtherapywithasimultaneousintegratedboostforbrainmetastases
AT zongyouchen dosimetriccomparisonofnoncoplanarvolumetricmodulatedarctherapyandnoncoplanarfixedfieldintensitymodulatedradiationtherapyinhippocampusavoidancewholebrainradiationtherapywithasimultaneousintegratedboostforbrainmetastases
AT shukuitang dosimetriccomparisonofnoncoplanarvolumetricmodulatedarctherapyandnoncoplanarfixedfieldintensitymodulatedradiationtherapyinhippocampusavoidancewholebrainradiationtherapywithasimultaneousintegratedboostforbrainmetastases
AT zunbeiwen dosimetriccomparisonofnoncoplanarvolumetricmodulatedarctherapyandnoncoplanarfixedfieldintensitymodulatedradiationtherapyinhippocampusavoidancewholebrainradiationtherapywithasimultaneousintegratedboostforbrainmetastases